论文

Ginsenoside Rg5 alleviates allergic rhinitis in rats by modulating nasal microbiota by inhibiting JAK2/STAT3/BCL-2 and MAPK signaling

作者:Chen Bai, Yue Zhang, Xiaohui Huo, Huifang Liu, Jiyue Sha , Yinshi Sun , Jianbo Chen

刊物名称:Journal of Ginseng Research

发表年月:January 2026

摘要内容:Background: Allergic rhinitis (AR) is a non infectious chronic inflammatory disease of nasal mucosa mediated by IgE and driven by type 2 immune response. Ginsenoside Rg5 (Rg5) is a bioactive compound derived from ginseng, but its effect on AR is unknown. Objective: This study investigated the therapeutic potential of Rg5 in toluene diisocyanate (TDI)-induced AR and explored its potential mechanism involving JAK2/SATAT3/BCL-2 and MAPK signaling pathways as well as nasal microbiota regulation. Methods: AR model was established by TDI sensitization and different doses of Rg5 were administered to assess symptom scores, IgE, His and cytokine levels. Nasal mucosal tissues and lung tissues were analyzed histopathologically for key proteins in the JAK2/STAT3/BCL-2 and MAPK pathways in the nasal mucosa. Nasal microbiota composition was assessed using 16S rRNA sequencing and signaling pathway correlation analysis was performed. Results: Rg5 significantly reduces IgE, His, and pro-inflammatory factors, increases anti-inflammatory factors, mitigates damage to the nasal mucosa and lung tissues, thereby alleviates nasal symptoms. It suppresses the activation of JAK2/STAT3 and MAPK pathways and upregulates BCL-2 expression. It also increases the abundance of Actinobacteria and Acidobacteria, decreases that of Bacteroidetes and Desulfobacteria, and restores the diversity of nasal microbiota. Rg5 ameliorates AR symptoms by enriching beneficial bacteria (e.g., Campylobacterota, Patescibacteria, and Acidobacteriota), regulating cytokine levels, and synergistically modulating the JAK2/STAT3/BCL-2 and MAPK pathways. Conclusion: Ginsenoside Rg5 acts synergistically through the JAK2/STAT3/BCL-2 and MAPK signaling pathways while restoring nasal microbiota homeostasis and attenuating TDI-induced AR symptoms, highlighting its potential as a novel therapeutic agent for AR.

图片6.png

人参皂苷Rg5显著减少了大鼠的过敏性鼻炎的症状

原文链接:DOI: 10.1016/j.jgr.2026.100984.